Financials

  • Market Capitalization 1.34 B
  • Employee 104
  • Founded 2005
  • CEO N/A
  • Website www.anaptysbio.com
  • Headquarter Delaware, United States
  • FIGI BBG0026ZDHR0
  • Industry Biotecnologia
Ricavi totali
Utile netto
Utile base per azione (EPS base)
Debito totale
Liquidità libera
Disponibilità liquide e mezzi equivalenti
Rapporto prezzo/utili
-105.39
Rapporto prezzo/fatturato
5.94

Related tickers

#NomePrezzo24h %7d %1M %1Y %Valore di MercatoUltimi 7 Giorni
2191
INBX
Inhibrx Biosciences, Inc. - Common Stock
95.01 USD+2.43%-2.61%-12.91%+17.91%1.40 B USD
2204
AAPG
Ascentage Pharma Group International - American Depository Shar
14.75 USD+1.37%-0.07%-9.68%-41.00%1.38 B USD
2232
GHRS
GH Research PLC - Ordinary Shares
21.11 USD+3.23%-8.22%-22.39%+49.08%1.31 B USD
2249
DRTS
Alpha Tau Medical Ltd. - Ordinary Shares
14.41 USD+2.93%-3.29%+2.13%+279.21%1.27 B USD

Notizie